Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice.

Suckow MA, Gutierrez LS, Risatti CA, Wolter WR, Taylor RE, Pollard M, Navari RM, Castellino FJ, Paoni NF. The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice. Cancer Lett. 2004 Jun 25; 209(2):165-9.

View in: PubMed

collapse authors with profiles